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Open access under CC BY-NOur recent work (Séralini et al., 2012) remains to date the most detailed study involving the life-long con-
sumption of an agricultural genetically modiﬁed organism (GMO). This is true especially for NK603 maize
for which only a 90-day test for commercial release was previously conducted using the same rat strain
(Hammond et al., 2004). It is also the ﬁrst long term detailed research on mammals exposed to a highly
diluted pesticide in its total formulation with adjuvants. This may explain why 75% of our ﬁrst criticisms
arising within a week, among publishing authors, come from plant biologists, some developing patents
on GMOs, even if it was a toxicological paper on mammals, and from Monsanto Company who owns both
the NK603 GMmaize and Roundup herbicide (R). Our study has limits like any one, and here we carefully
answer to all criticisms from agencies, consultants and scientists, that were sent to the Editor or to our-
selves. At this level, a full debate is biased if the toxicity tests on mammals of NK603 and R obtained by
Monsanto Company remain conﬁdential and thus unavailable in an electronic format for the whole sci-
entiﬁc community to conduct independent scrutiny of the raw data. In our article, the conclusions of
long-term NK603 and Roundup toxicities came from the statistically highly discriminant ﬁndings at
the biochemical level in treated groups in comparison to controls, because these ﬁndings do correspond
in an blinded analysis to the pathologies observed in organs, that were in turn linked to the deaths by
anatomopathologists. GM NK603 and R cannot be regarded as safe to date.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Our recent publication of research evaluating the long term tox-
icity of a NK603 Roundup-tolerant genetically modiﬁed (GM)
maize and of a Roundup (R) herbicide (Séralini et al., 2012) has
provoked numerous positive and negative reactions throughout
the world. This is the way science moves forward and here we pro-
vide a response to this intense debate. Our work is the most de-
tailed study involving the life-long consumption of an
agricultural genetically modiﬁed organism (GMO), and especially
on NK603 for which only a 90-day safety test was previously con-
ducted and using the same rat strain (Hammond et al., 2004). It is
also the ﬁrst long term detailed research on mammals exposed to a
highly diluted pesticide in its total formulation with adjuvants.
These adjuvants help to stabilize the active principles of pesticides,
and promote a better penetration into organisms, and thus more
side-effects. R is the most widely used herbicide in the world,t.2012.10.057
C-ND license. which we tested from levels arising in tap water. Indeed in our
study, its active principle glyphosate (G) was not studied alone,
contrasting with the long term experiments conducted by the
manufacturer as part of its application for regulatory approval.
As such, the debate in question here is at the cornerstone of science
and regulatory issues on this topic. This fact has major economic
ramiﬁcations for the development of such products, which can ex-
plain the severe comments posted within hours of our publication
becoming available online. This may explain why 75% of our ﬁrst
criticisms arising within a week, among publishing authors, come
from plant biologists, some developing patents on GMOs, even if
it was a toxicological paper on mammals, and from Monsanto
Company who owns both the NK603 GM maize and R herbicide.
We must ﬁrstly focus on science. Our work is a research study;
it has not a direct regulatory purpose and should not be considered
as a ﬁnal point in knowing the toxicological effects of NK603 and R.
This is a ﬁrst step in the iterative investigation of the long-term
health effects on mammals of these commercial products that
should be replicated independently, as well as on developing
mammals. It has limits like any study, and here we carefully an-
swer to all criticisms from agencies, consultants and scientists, that
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selves. These challenged our results and the validity of our proto-
col, some letters even requested the withdrawal of the
publication from the journal. All remarks and answers are summa-
rized in Table 1 and with some explanatory details given below.
At this level, a full debate is biased if the toxicity tests on mam-
mals of NK603 and R obtained by Monsanto Company remain con-
ﬁdential and thus unavailable for the scientiﬁc community to
conduct independent scrutiny of their raw data. This is why, after
several exchanges, we requested again from the European Food
Safety Agency (EFSA) on September 20th and October 18th 2012
the release on a public website of the raw data on health risks on
the basis of which commercialization of these products was
granted, in particular results from the longest study of NK603
and Roundup on mammals (Hammond et al., 2004). We ask for a
free and transparent exchange of scientiﬁc ﬁndings, mainly when
these are related to public health and environmental risks (Schre-
ider et al., 2010). Examination of industry raw data previously evi-
denced divergence of regulatory decisions from scientiﬁc evidence
underestimating toxicological features of G (Antoniou et al., 2012).
We recall that the tests on rats are usually considered as a model
for mammalian health before clinical trials (for example for phar-
maceuticals) or for a direct market release (for novel food and feed,
pesticides or chemicals). Moreover, tests on rats are also models for
environmental risk assessment, since they are models for other
wildlife mammals. The public release of these raw data will reveal
if signiﬁcant differences observed between test and control groups
in both studies are coherent and if the statistics are of sufﬁcient
power in both cases, thereby allowing the design of appropriate
follow-up experiments by others, perhaps through a publically dis-
cussed and agreed protocol.2. Relevance of the scientiﬁc context
Some remarks emphasize a lack of context, claiming that the
study was performed for non-scientiﬁc reasons. The establishment
of this protocol was however the consequence of an intense debate
about the biological relevance of numerous statistically signiﬁcant
differences compared to controls revealed and admitted to in 90-
day feeding studies with agricultural GMOs (Spiroux de Vendomois
et al., 2010). This is highly controversial, with companies and reg-
ulatory agencies having refuted ﬁndings, which were validated by
a peer reviewed process in international journals (EFSA, 2007;
Séralini et al., 2007). Indeed, regulatory agencies such as EFSA ap-
pear to have their own criteria to judge the biological relevance of
research ﬁndings (Doull et al., 2007), which is markedly at odds
with some recent knowledge. This includes cases of sex speciﬁc
non-linear endocrine disruptions, which were not admitted to as
valid at a regulatory level although accepted at a scientiﬁc research
level (Myers et al., 2009b). In order to overcome the divergence in
biological interpretation of early signs of toxicity in blood bio-
chemistry for GMOs, one solution was to prolong 90-day feeding
tests to chronic periods. We therefore chose the R tolerant
NK603 GM maize because R tolerance is the trait present in
approximately 80% of agricultural GMOs (James, 2011) and be-
cause statistical differences in the 90-day feeding trial with this
maize were admitted to by both the petitioner and regulatory
agencies (EFSA, 2009).3. Originality and limits of the experimental design
Due to the economic and regulatory issues of this topic, it is not
surprising that our research study was confounded with pre-com-
mercial regulatory assessments. This is why the most common
criticism questions the following of Organization for EconomicCo-operation and Development (OECD) guidelines. However, no
guidelines exist for GMO toxicity studies in vivo, which are still
not mandatory. Published reviews have conﬁrmed that most of
the studies conducted to date did not follow speciﬁc guidelines
or were contradictory (Domingo, 2007; Domingo and Giné Bordon-
aba, 2011). We compared our design (Table 1 of Séralini et al.,
2012) to Hammond et al. (2004) inspired from OECD guideline
408 for chemicals. We have replicated, extended and thus im-
proved the experiments conducted by Hammond and colleagues
(Hammond et al., 2004) by measuring outcomes from 3 instead
of 2 feed doses and more crucially for a period 8 times longer in
duration (90-days vs 2 years), with 11 blood and urine measures
of around 50 parameters, 34 organs instead of 17, etc., in order
to ascertain if the statistical ﬁndings (observed at 90 days; Ham-
mond et al., 2004), were biologically relevant or not in the long
term. We thus biochemically measured 10 rats per sex per group
as performed by Monsanto. Even for a study of up to two years,
we had no reason to monitor biochemical effects on more than
10 animals per sex per group as this is the number recommended
in OECD guideline 452 for chronic toxicity testing (OECD 1981 was
in application when the study started in 2008), even if 20 animals
per group or more are possible.
The purpose of the addition of R treated groups was not to as-
sess R long term carcinogenesis, which needs to follow OECD 453
guideline with at least 50 rats per sex per group (even if 10 rats
are then still measured at a biochemical level). The aim of our
study was to test R under similar conditions to the GMmaize in or-
der to try and understand if residues of R in the feed could explain
the possible pathologies that may arise. There were two main po-
tential sources of harm tested in our study: (i) effects from the GM
maize itself, treated or not with R, and (ii) herbicide residues alone
in drinking water, using 3 doses for each treatment. We recall that
the initial investigation published by Hammond and colleagues
(Hammond et al., 2004) used 2 doses for each treatment group de-
spite that fact that 3 doses are recommended by OECD guideline
408, which they reported to have followed.
In addition, one of the criteria for biological relevance employed
by Monsanto and other critics of our study is the linearity or lack
thereof in response to the dose. Such a dose–response relationship
cannot be claimed from a trial using only 2 doses of test material as
employed in the initial NK603 assessment (Hammond et al., 2004).
We therefore ﬁnd it surprising that the relevance of Monsanto’s
and the agencies’ conclusion of safety was not challenged due to
such protocol insufﬁciencies. A recent review of the literature is of-
ten cited as a proof of the safety of GMO consumption on a long-
term basis (Snell et al., 2012). However, of the 24 studies they eval-
uated, only 2 are long-term on rodents, since a 2 year feeding per-
iod with pigs or cows do not constitute a life-long experiments. The
2 rodent studies quoted by Snell and colleagues are from Sakamoto
et al. (2008) where not all rats fed transgenic soy were analyzed,
and Malatesta et al. (2008a) in mice fed again GM soy, which
showed at an electronic microscopy level effects of this product
on hepatic function. Moreover, of the 24 studies cited, 16 did not
mention the use of the closest isogenic non-GM line as a control,
many did not describe the methods in detail, and contained addi-
tional deﬁciencies (Snell et al., 2012). However, all these studies
were accepted as proof of safety regardless of the inadequacies
highlighted here. It would appear that conclusions of safety seem
to need fewer requirements than conclusions of toxicity. However,
scientiﬁcally it is easier to conclude an outcome of toxicity than
safety. This was not the ﬁrst time regulatory agencies used such
double standards to minimize independent research ﬁndings in re-
gard to industry ﬁndings (Hilbeck et al., 2012; Myers et al., 2009a).
Our control groups were also questioned and this needs some clar-
iﬁcation. Some claimed that controls are lacking for all 4 test
groups (GMO+R and GMO alone at 11% and 22%). We compared
Table 1
Summary of criticisms and responses on Séralini et al. long-term NK603 GM maize and Roundup toxicity rat study.
Criticisms Answers
Relevance of the scientiﬁc context
No scientiﬁc context This study addresses biological interpretations of early signs of toxicity in
biochemistry after 90-day feeding trials (Spiroux de Vendomois et al., 2010)
OECD guidelines not respected No guidelines exist for GMO animal studies. Protocol based and adapted from
OECD 408 and 452
Protocol not adapted to tumor ﬁndings This is not a carcinogenesis study, but a long term full toxicological study
GLP violation because of amendments Research protocols not adapted to GLP agreement because of amendments. The
experiment was conducted under a GLP environment and conditions
History of ﬂaw by the authors which are not toxicologists. Previous studies of the
group rejected
More than 26 international scientiﬁc peer reviewed papers by the team with the
lead author on the topic in the last 5 years, and 11 in toxicological journals on the
same period only in PubMed. One author, Malatesta, has also published on GMO/
pesticide health risks. None of the papers was considered as ﬂawed by the
scientiﬁc community. Regulatory agencies or Monsanto are not scientiﬁc peer
reviewed journal systems
Lack of signs in 90 days Statistical differences in biochemical parameters of liver and kidney function
recognized by both industry and agencies
Not the ﬁrst long term study First chronic investigation with NK603 GM maize; others of two years in farm
animals are not over the entire lifespan; the most detailed study for all agricultural
GMOs and a formulated pesticide
Originality and limits of the experimental design
Choice of the rat strain (sensitivity to mammary tumors and nephropathies in
males)
Necessity to have sensitive strains, recommended by the US National Toxicology
Program (King-Herbert et al. 2010). Rats and mice have been preferred
experimental models because of their susceptibility to tumor induction (OECD
guidelines) Relevant comparisons to controls in this work
Number of rats per group OECD 408 (90-day toxicity study) 10 animals per group OECD 452 (Chronic
toxicity study) 20 animals per group but at least 10 animals per group are studied
for hematological and clinical biochemical function
Missing data: diet composition and process, PCR analysis of batches, contaminants
(mycotoxins, pesticides), storage (R in water, BPA, feed), isogenic line, culture
conditions
Normally included in GLP environment studies. No possibility to detail all these
data in this scientiﬁc study in this journal – in process of publication. Diet
equilibrated for substantial equivalence between GMO and the closest isogenic
line and other compounds. Other points detailed in the text
No blinding, not the knowledge to interpret tumors, no morphometric analyses, no
use of PETO codes, no classiﬁcation
Independent and blinded analysis by GLP performed by professional regulatory
anatomopathologists. Nature of most frequent tumors in Fig. 3 legend and results.
A professional report for each rat indicates the cause of mortality
R formulations are different Depends on the country
Controls not sufﬁcient (number of rats per group, 4 groups 11 and 22%, no drinking
water control group)
Number of rats approved in guidelines, best in the world at this level of details for
these products. All the animals have eaten 33% of maize and substantially
equivalent diets. Only R treated rats had received R in water
No reference groups, no lab historical data Reference groups add irrelevant variability with non-substantially equivalent
diets; historical data contain diets not controlled for pesticides and GMOs, thus
not relevant
Ad Libitum feeding In accordance to guidelines and usual practices
Diurnal variations All samplings were taken at the same time
Focus on statistics
Not enough statistical power
No Kaplan Meier’s curves
Variability expected by chance
Only raw data in Figs. 1–3 and Table 2
Statistics do not tell the truth, but may help in understanding results. The
biological interpretations and the crossing of methodologies are the key. Enough
and high statistical power for OPLS-DA, and this is why raw data only were
presented in Figs. 1 and 2 and Table 2; no statistical power of Kaplan Meier’s
analyses for a conclusion demonstrating effects or no effects.
No means and standard deviations in Table 3 OPLS-DA is not a method to compare mean differences which were presented for
understanding of biochemical measurements with highly discriminant parameters
in bold
Pertinence of the results
Missing data (Behavioral studies, ophthalmology, microbiology in feces and in
infectious nodules, G in tissues, body and organ weights, feed and water
consumptions, transgene in tissues, time effects)
All measures cannot be presented in one paper and will be the subject of other
publications. The other analyses are not relevant for the conclusions presented
No isoﬂavones in maize Testing the diets for phytoestrogens is relevant because the equilibrated diet (non-
GM) contains other components
Phenolic acids in the normal range Used as biomarkers indicative of change in the metabolism of the GMO. This does
not exclude the presence of unknown toxic compounds
No incidence / severity Lack of histopathology data Taken into account as indicated in the legend of Table 2 which consists in a
summary of the most relevant data
Endocrine disruption not sufﬁciently supported Convergent body of evidence stemming from mammary tumors, pituitary
dysfunctions, histopathology and sex hormone biochemistry
Wilm’s tumors are only of genetic origin Promotion by pesticide exposure is plausible and as evidenced by gestational
exposure described in the literature
Feeding state explains glycogen in electron microscopy No difference in feed consumption; experience in the domain by M. Malatesta
Pictures of control rat not shown Rats representative of each group shown, controls do not present tumors in
majority during the experiment, pictures non necessary
Discussion: ﬁndings in regard with the contradictory hypotheses
R is not a sex endocrine disruptor This is still true at a regulatory but not at a scientiﬁc research level. R endocrine
disrupting properties are described in vivo and in vitro (references in the text).
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Table 1 (continued)
Criticisms Answers
Regulatory classiﬁcation should be in process
G is not toxic in two-year tests G is never used alone in agriculture, but in formulations with G far more toxic than
G alone; G tests are not relevant, we used R
G is close in structure to amino acids and surfactant exposure is as soap exposure This is not supported by the scientiﬁc literature; the structural and activity
comparisons are not scientiﬁcally relevant to predict with certainty toxicological
effects or safety
No effects on farm animals and in human population of the USA No epidemiology, no life-long experimental studies; farms animals are generally
killed too young to show development of long term diseases. No traceability and
labeling of GMOs in USA, no epidemiological survey can be performed
Sakamoto et al. 2008 not reported This study does not use the same GMO (soy vs maize) and neither the same strain
of rat. No effect for GM soy in F344 rats is claimed but does not imply the same for
NK603 GM maize in SD rats
Raw data expected for our study Raw data also expected for regulatory accepted tests for this GMO and this
pesticide to scientiﬁcally discuss details
Ethical issues and deontology
Maize illicitly grown Not at all; grown and imported with appropriate authorizations
Animal welfare problems, a veterinarian would not authorize such tumor
development
The work follows GLP conditions. All rats followed by veterinarians on the site,
applying the rules of the ethical committee and guidelines
Conﬂicts of interests No conﬂict for us. Conﬂicts of interests for companies testing their own products
Role of funders See acknowledgments, funders identiﬁed. No interference in study or results;
conﬁdential up to the embargo
Publication released before for journalists Everything was released on the same day (September 19th), in accordance with
the conditions set by the FCT editorial board.
Conﬁdentiality agreement unusual The conﬁdentiality of the work is a usual practice before embargo
The authors should alert agencies from the end of experiment instead of waiting
for a publication
The publication and reviewing of the work is the guarantee of quality with no
interference
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est available isogenic maize, as all diets were equilibrated to 33%
maize; that is, for example the 11% GM maize diet was supple-
mented with non-GM control maize to reach 33%. More accurately
the closest available isogenic line was the DKC2675 variety com-
pared to the DKC2978 GMmaize (NK603). Regulatory agencies also
questioned the conditions under which the maize was grown. One
R treatment was applied 4 months before harvest. Fungicides were
applied similarly. We were unable to use the same R formulation in
the ﬁeld (Canada) and in the drinking water of the rats (France) be-
cause authorized formulations vary between nations. The diet was
nutritionally equilibrated from substantially equivalent maize and
was then checked by PCR for GMO content. A major concern was
the potential presence of mycotoxins. Fumonisin B1 and B2, zearal-
enone, deoxynivalenol (DON), nivalenol, 3-acetyl-DON, 15-acetyl-
DON, fusarenone X, T2 toxin, HT2 toxin and diacetoxyscirpenol
were all under recommended limits in food/feed used in this study.
We did not present details of each of these substances when no
particular changes affecting the understanding of the results were
noticed.
As a research protocol, Good Laboratory Practice (GLP, OECD,
1997; 2004/10/EC regulation) was followed, meaning that housing
conditions, manufacturing process, diet composition and storage,
stability of solutions and dietary contaminants were assessed by
approved laboratories. Anatomopathology was performed in a
blind manner (without knowing the treatments) by professional
anatomopathologists approved for regulatory purposes. An elec-
tronic chip was inserted in each rat for identiﬁcation. However,
the technicians employed for the care and sampling of the animals
did not know either the nature of the diets or the drinking water
prepared independently, or which was the control group. The cages
housing the animals were moved within holding rooms regularly
and similarly for all animals. The blood (1 mL) and urine samples
were coded and the measurement of biochemical parameters also
blind, as were the decisions of euthanasia to avoid suffering in
accordance with precise regulatory ethical rules (hemorrhages,
impossibility to drink and eat, large tumors over 25% body weight
because they provoke mortality). All the animals were monitoredduring the experiment by professional veterinarians. The statistical
analysis was also undertaken on coded groups. However, we have
made research amendments adding additional analyses (tissue and
biochemical parameters) adapted to the ﬁndings in order to im-
prove the understanding of the pathologies, thus we are only in a
GLP environment. Generally, it is standard practice that a regula-
tory agency does not take note of research studies because they
are not conducted under GLP conditions (Myers et al., 2009a). By
its very nature, a research protocol is rarely compatible with GLP
agreements. GLP agreement is a good tool to normalize regulatory
assessment but research studies need a greater degree of freedom,
in test protocols, models, etc.4. Rat strain
We would like to explain the choice of the strain of rat. This is
another redundant remark made by critics of our study design. We
recall that OECD norms (408, 452 and 453) are not prescriptive for
the strain of rat to be used. Sprague Dawley (SD) rats are subject to
spontaneous neoplasms and this property is supposed to invalidate
them being used as a model for carcinogenesis. However, on the
contrary, the fact that the SD strain develops tumors, hence has
led to it is preferentially used by some agencies such as for the Na-
tional Toxicology Program using it for 2-year carcinogenicity and
other long-term studies (King-Herbert et al., 2010). Indeed, it
would be a non-sense to study pathologies in a strain insensitive
to tumor formation. Long-term OECD guideline 452 even states
that rats and mice have been preferred as experimental model sys-
tems because of their susceptibility to tumor induction. The same
reasoning is used for chronic progressive nephropathies (CPN)
developed by SD rats. The fact that the strain developed spontane-
ous CPN with age (Hard and Khan, 2004) does not invalidate the
model as we looked at the difference in the chronology, age, num-
ber and severity of CPN in comparison to controls.
To assess the biological relevance of results, many authors make
comparisons with historical data of control rats, either within the
laboratory or the breeding company from which animals are
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and heightens the risk of false negative ﬁndings (Cuffe, 2011). It is
now established that this concept should be used with caution.
There are several reasons for this. Control diets for rats are gener-
ally not monitored, neither for pesticides (Hayes, 2004), nor for
chemicals leaching from cages or other environmental sources
(Howdeshell et al., 2003). This artiﬁcially enhances background ef-
fects. The supplier even recognizes that their historical data come
from rats potentially fed GMOs since this was not controlled for
(Harlan communication), except in our experiment. Thus, it was
not appropriate for us to use historical control data. This is also
the reason why we did not use reference groups fed different
non-substantially equivalent diets, as they increase the standard
deviation of the control groups, hiding differential effects due to
treatments.
Many non-relevant remarks have also been noticed. Among
others, some criticized the use of ad libitum feed to explain the in-
crease of tumor incidence. Guidelines on the design and conduct of
chronic toxicity studies state that rodents should be fed and wa-
tered ad libitum (OECD, Guidance Document No. 116). The hor-
monal imbalances were criticized to be due to diurnal or cyclic
variations. However, sampling was performed at the same time
each day in the morning.5. Focus on statistical analytical methods and outcomes
Statistics do not tell the truth, but may assist in our understand-
ing of experimental outcomes. The biological interpretations and
the crossing of methodologies are the key (Cooper and Kavlock,
1997). We have applied the most modern statistical methods
(OPLS-DA, see below) for multivariate data analysis of approxi-
mately 50 parameters measured 11 times for 200 rats. This al-
lowed, in a blinded manner, to obtain results signiﬁcantly
discriminant at 99% conﬁdence levels. These discriminant bio-
chemical markers were, for example in the case of sexual hor-
mones (at 95% for females at month 15), when the differences in
hormone-dependent tumor incidence with the control group be-
gan. Disability in pituitary function was characteristic of this sec-
ond most affected organ as certiﬁed independently by the
pathologists in a blinded manner in treated female groups in com-
parison to controls. Such a disturbance in hormonal function is
known to elicit mammary tumors in rats with the pituitary being
a target of endocrine disrupting chemicals (Wozniak et al., 2005).
The pathologists employed in our study explained that most of
the mortality in females resulted from tumors, which led to eutha-
nasia independently of the grade of cancer. This is why we did not
detail the grade of tumors in our research but with the cancerous
nature of the major tumor growths described in our study (Fig. 3
legend and results section (Par. 3.2)). These observations together
with microscopic analysis reinforced our conclusions.
We believe all this was more pertinent than the study of statis-
tically non-powerful Kaplan–Meiers’ curves on survival (because of
the groups of 10 animals per sex dying progressively) that cannot
allow any conclusion on mortality linked or not to the treatment.
Taking into account these limits, we decided to be simply factual
in our presentation and thus describe the chronology and inci-
dence of tumors and deaths. In comparison, statisticians from
agencies could evaluate the power of the statistical analyses of
the tests conducted by Hammond et al. (2004), which gave a score
of safety, and that were used for market release. For us, the power
of statistics used in Hammond et al. (2004) is extremely low to
conclude to safety.
In our study, case PLS-regression (Projections to Latent Struc-
tures by means of partial least squares) is of particular relevance
because, unlike conventional multivariate data analytical methods,it can analyze data sets with variables more numerous than obser-
vations, which can be strongly correlated (Wold et al., 2001). In the
case of Orthogonal Partial Least Squares Discriminant Analysis
(OPLS-DA) there is separation between the inter-group variation
(represented on the predictive component) and the intra-group
variation (variability of the samples, represented on the ﬁrst Y-
orthogonal components). OPLS-DA is thus not an appropriate
method with which to compare mean differences. However, for
providing biochemical understanding, we have presented and
highlighted those in Table 3 of our study, with highly discriminant
parameters in bold text. OPLS-DA renders it possible to identify
which variables are responsible for the separation of the groups.
For instance, we also indicate in Fig. 5B that estradiol and testoster-
one are signiﬁcantly discriminant at 95% conﬁdence levels in some
groups (not at 99% like other parameters presented).
Moreover, the SIMCA-P (V12) software (UMETRICS AB Umea,
Sweden) for the multivariate analysis of biochemical data uses a
method of validation of models, which is a k-fold cross-validation.
The Q2(Y) parameter which measures the predictive ability of the
models is calculated according to this cross-validation method.
Only valid models with a satisfactory predictive quality Q2 index
were retained for the selection of the discriminant variables (bold
in ﬁgures, Table 3). Furthermore, all models retained are signiﬁcant
(CV-ANOVA test with p-value <5%). One of the authors of our paper
(D.H.) previously used this method and published their results in
international peer-reviewed journals (Ledauphin et al., 2010;
Malzert-Freon et al., 2010a; Malzert-Freon et al., 2010b).6. Pertinence of the results
The ﬁrst major criticisms that were raised concerned the results
and their format of presentation. A scientiﬁc publication is by
necessity limited in ﬁgures/tables and only shows the data neces-
sary to understand and discuss the conclusions. This is why behav-
ioral studies, ophthalmology, microbiology in feces and in
infectious nodules, G in tissues, body and organ weights, feed
and water consumptions, transgene in tissues, time effects will
be the subject of future publications. The inclusion of these data
at this stage would neither add to the main message nor would
it improve the understanding of this ﬁrst publication. Indeed, the
peer review process has controlled the logic of the body of data
presented. Additional sets of results were included in the revision
of the manuscript in response to issues raised by the reviewers
prior to publication.
The second major criticism of the results is that we attached too
much importance to ﬁndings related to mortality and tumor rela-
tive to their scientiﬁc signiﬁcance. We are aware of the limitations
of these ﬁndings as discussed above in relation to the statistical
analysis undertaken. The body of evidence for our conclusions
comes from the converging methodologies and data (see Focus
on Statistics). The variability in rates of mortality can indeed, if
looked at in isolation, arise in principle by chance. However, statis-
tical analysis for Figs. 1 and 2 is not of sufﬁcient power to conclude
that this is the case or the contrary. This is why we have presented
the raw data for these sets of observations. For instance, males pre-
sented up to 4 times (2 times of the mean) more large palpable tu-
mors than controls, similarly to that observed in female animals.
As these observations may represent a potential risk for the human
population, this cannot simply be disregarded so rapidly with non-
potent statistics. This is also why we emphasized statistically dis-
criminant biochemical effects at the 15th month, when most of
animals were still alive (in treated groups 90% males, 94% females,
and 100% controls). The signiﬁcantly discriminant biochemical
markers disrupted do correspond to the organic markers linked
to the pathologies in a blinded analysis for the pathologists, who
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fed groups linked to premature deaths was criticized for bringing
confusion to the results, because these tumors are often of embry-
onic and/or genetic origin. However, these tumors are also known
to be promoted by pesticide exposure (Fear et al., 1998).
The summary of the major histopathological ﬁndings in Table 2
was subject to the same criticisms. In fact, we indicated the sever-
ities of the CPN and only marked or severe CPN were shown. In-
deed, elderly rats are subject to CPN and taking into account all
CPN could hide interesting and important differences. The power
of statistics may be discussed as for Figs. 1 and 2. However, all
these data need to be seen in the context of all the signiﬁcant re-
sults presented in the paper, as previously underlined.
For the ﬁndings obtained from the electron microscopy analy-
sis, it is important to compare our results with those reported pre-
viously. Several studies have shown ultrastructural abnormalities
in the liver of mice fed with GM soy (Malatesta et al., 2002) and
that this structural disturbance was reproduced by adding the her-
bicide R directly to rat hepatocytes (Malatesta et al., 2008b). We
thus wanted to test if the same disruptions can be seen in the liver
of the rats in our experiment. This was indeed the case, and fur-
thermore these observations conform with ours and others pub-
lished in vitro effects of R (Gasnier et al., 2010, 2011). Glycogen
dispersion or appearance in lakes found by electron microscopy
was attributed to the feeding state by some critics. However, dif-
ferences in feed consumption were not observed during the course
of our study. Not only appearance of glycogen in lakes was noticed,
but also a reduced rate of transcription of mRNA and rRNA, which
is not normally known to be due to the feeding state, but rather to
a toxic insult. Ultrastructural patterns revealed by of electron
microscopy were coherent with an increase in detoxifying activity
in liver, and this is corroborated by differences in cytochrome en-
zyme activities.
A major gap in some toxicological assessments is the lack of
measurements investigating endocrine disrupting effects (Birn-
baum, 2012). As noted previously, the central dogma in toxicology
is that effects vary linearly to dose. This is true for standard poison
intoxication. However, toxins with endocrine disruptive properties
can give response curves that are U, inverted U or J in shape and are
frequently observed in the case of exposure to environmental pol-
lutants (Vandenberg et al., 2012). Endocrine disturbance is sup-
ported by observations in human (Gasnier et al., 2009) and rat
testicular cells for R residues (Clair et al., 2012). In our study it is
demonstrated by statistically signiﬁcant sex hormone imbalances
and disabled pituitary function. Moreover, doses varied from
50 ng/L to 2.5 g/L of glyphosate in R; that is, a factor 50 million,
from which we cannot expect linear effects with such a wide range
of doses tested, characteristic of the range of different kinds of
environmental exposures (tap water, GM food and feed, diluted
agricultural use). The kidneys and liver are also sensitive to endo-
crine disruptors. As the two major detoxifying organs, containing
cytochrome P450 or other enzymes involved in xenobiotic or sex
steroid metabolism, they often react with steroid sex hormone
and related compounds (Pascussi et al., 2008).
Last but not least, we have identiﬁed phenolic acids as potential
biomarkers of metabolic disturbances in the GM diet. We have also
measured isoﬂavones in the diet even though maize does not pro-
duce these compounds. Rats indeed did not eat only maize but also
other plants in an equilibrated diet. Even OECD 452 guidelines on
chronic toxicity ask for testing phytoestrogen content of the diet.
Importantly, decrease in phenolic acids is a good indicator of
change in the metabolism of the GMO that could in turn lead to
a reduced protection against the pathologies observed in the ani-
mals fed the NK603 GM maize. However, this does not exclude
the possibility of other toxic effects of the GMO alone, which have
not been identiﬁed in the experiment.7. Discussion
7.1. Findings in regard with the contradictory hypotheses
Critics have claimed that no argument exists for R to be a sex
hormone endocrine disruptor, which is based on a review by Wil-
liams et al. (2000), where most of the studies cover G effects alone
and not R. We wish to draw attention again to the fact that G is
never used as such, but in formulations with other substances
allowing toxicity, both of target and non-target species. This is
extensively described for G-based herbicides, but also for other
pesticides (Eddleston et al., 2012). This is why, in our opinion, all
discussion of our study referring to testing of G alone is not rele-
vant. Furthermore, we ﬁnd it incomprehensible that non-scientiﬁc
assertions justify R innocuousness by the structural homology of G
with non-toxic amino acids. In addition adjuvants in the R formu-
lation cannot be judged harmless by a comparison of their activity
to soap. There is no scientiﬁc basis to use these assertions to pre-
dict with certainty toxicological effects or safety. The fact that G
alone is neither a carcinogen nor an endocrine disruptor in regula-
tory tests is not a proof of the safety of whole R formulations, espe-
cially when some formulations contained toxic compounds (Cox,
2004). The unexpected ﬁnding of new active principles with hu-
man cell toxicity capabilities in G-based herbicides has challenged
the relevance of testing G alone as the active principle in R (Mes-
nage et al., 2012). R has already been demonstrated to be an endo-
crine disruptor in vivo (Dallegrave et al., 2007; Oliveira et al., 2007;
Romano et al., 2010, 2012) with the underlying mechanism under-
stood in vitro.
Several studies have shown signiﬁcant endocrine disrupting ef-
fects of R, such as decrease in progesterone production, decreased
levels of Steroidogenic Acute Regulatory (StAR) mRNA production
in MA-10 mouse Leydig cells (Walsh et al., 2000), decrease in aro-
matase mRNA and activity levels in JEG3 cells and placental and
equine testicular microsomes (Richard et al., 2005; Benachour
et al., 2007), inhibition of transcriptional activities of androgens
and of both a- and b-estrogen receptors in cells (Gasnier et al.,
2009), and a decrease in testosterone production in rat Leydig cells
(Clair et al., 2012). All these studies reinforce the biological rele-
vance of our ﬁndings.
Some critics have emphasized that no adverse effects have been
reported on either farm animals or in the human population of the
USA who have consumed an unknown mixture GMO crop derived
food. Such claims are scientiﬁcally unsound for the following rea-
sons. First, it is important to note that there have been neither epi-
demiological studies of the human population nor monitoring of
farm animals in an attempt to correlate any ill-health observed
with the consumption of a given GM crop. Second, it should be re-
called that farm animals are not reared to live for the entire dura-
tion of their natural lifespan, and thus usually do not live long
enough to develop long-term chronic diseases, which contrasts
with the rats in our life-long experiment. If any studies in lactating
cows are conducted, biological analyses performed are far less
complete than those done in regulatory tests using rodents includ-
ing in our study. Third, as there is no labeling of GMO food and feed
in the USA, the amount consumed is unknown, and no ‘‘control
group’’ exists. Thus, without a clear traceability or labeling, no epi-
demiological survey can be performed.7.2. Ethical issues
Many critics argue against our refusal to release all the raw data
generated in our study. This is a very unusual request when we
clearly stated that we plan several other papers out of this data
set. Our study was not performed for regulatory purposes. How-
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of the potential risks associated NK603 GM maize and R, we will
release our raw data if the regulatory agencies that have taken
industry data into account in their approval of their products also
release the data pertinent for environmental and health risk
assessments, in particular their longest toxicological tests on mam-
mals, as we have indicated in our correspondence with EFSA. As a
ﬁrst step to this end, we have communicated the raw data under-
lying the data presented in Figs. 1 and 2 to the French food safety
agency (ANSES), and answered their questions on experimental de-
sign and results, including analysis of food composition and myco-
toxin content, etc.
Most of the criticisms on the topic of ethical conduct relate to
animal welfare, some thinking that we overpassed the threshold
in size of tumors above which animals should be euthanized, with
the purpose of taking shocking photographs. However, it should be
recalled that in a GLP environment, animal welfare is of major con-
cern and that we fully respected the threshold in tumor size before
euthanasia. Pictures of every animal and organ were taken. We
presented those related to the most observed pathologies, includ-
ing those of a microscopic nature, for illustrative purposes in
Fig. 3, with rats representative of each group.
Some critics raised concerns about the role of the funders of this
work, and possible conﬂicts of interest. Of course, the funders nei-
ther played a role in the design and conduct of the experiment, and
nor in its interpretation. The data remained conﬁdential to the
funders. We recall that in the regulatory assessment of GMOs,
chemicals and medicines, tests are conducted by the applying com-
panies themselves, often in their own laboratories. As a result, con-
ﬂicts of interest exist in these cases. These are even not claimed by
authors from the company defending the safety of the tested prod-
ucts (Hammond et al., 2012). Our study does not aim to request
commercialization of a new product. In contrast, we wanted to
estimate the health risk of these products. It is the most detailed
test conducted to date that is also independent from biotechnology
and pesticide companies. We encourage others to replicate such
chronic experiments, with greater statistical power. What is now
urgently required is for the burden of proof to be obtained exper-
imentally by studies conducted independent from industry. This
was recommended by regulatory agencies in France that have as-
sessed our work, even though their objective is more to regulate
products than to review research. GM NK603 and R cannot be re-
garded as safe to date.Conﬂict of Interest
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